Open-source automated insulin delivery systems, commonly referred to as do-it-yourself automated insulin delivery systems, are examples of user-driven innovations that were co-created and supported by an online community who were directly affected by diabetes. Their uptake continues to increase globally, with current estimates suggesting several thousand active users worldwide. Real-world user-driven evidence is growing and provides insights into safety and effectiveness of these systems. The aim of this consensus statement is two-fold. Firstly, it provides a review of the current evidence, description of the technologies, and discusses the ethics and legal considerations for these systems from an international perspective. Secondly, it provides a much-needed international health-care consensus supporting the implementation of open-source systems in clinical settings, with detailed clinical guidance. This consensus also provides important recommendations for key stakeholders that are involved in diabetes technologies, including developers, regulators, and industry, and provides medico-legal and ethical support for patient-driven, open-source innovations.

• MeSH
• Diabetes Mellitus, Type 1 * drug therapy   MeSH
• Hypoglycemic Agents therapeutic use   MeSH
• Insulin * therapeutic use   MeSH
• Insulin Infusion Systems MeSH
• Humans MeSH
• Health Personnel MeSH
• Check Tag
• Humans MeSH
• Publication type
• Journal Article MeSH
• Research Support, Non-U.S. Gov't MeSH
• Review MeSH
• Research Support, N.I.H., Extramural MeSH

Use of real-time continuous glucose monitors among people with type 1 and type 2 diabetes is growing rapidly and should continue to grow until an artificial pancreas is brought to market. Likewise, use of professional systems in healthcare practices is expanding. But, other than manufacturer instructional manuals and some book chapters on CGMs, there are no standalone publications available with concise, non-commercial instructions on CGM prescription and use. Additionally, continuous glucose monitors are too often not used to their full and proper potential. This leaves users with suboptimal glucose control and can result in system abandonment. To address this, diabetes educator and author Gary Scheiner has created Practical CGM: Improving Patient Outcomes through Continuous Glucose Monitoring to give healthcare providers the skill to make more effective use of the data generated by continuous glucose monitors, in both real-time and on a retrospective analytic basis. Using a plain-language approach and distilling content to concise, practical tips and techniques, Scheiner has created a guide that will help practitioners optimize patient use of CGM systems and, ultimately, improve glucose control and patient health outcomes

• MeSH
• Diabetes Mellitus blood   MeSH
• Blood Glucose Self-Monitoring * instrumentation   MeSH
• Publication type
• Handbook MeSH

• Conspectus
• Patologie. Klinická medicína
• NML Fields
• diabetologie